| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Prelude Therapeutics Inc | CEO, Director | Common Stock | 1.07M | $4.02M | $3.77 | May 25, 2023 | Direct |
| Prelude Therapeutics Inc | CEO, Director | Common Stock | 424K | $1.6M | $3.77 | May 24, 2023 | By Trust |
| Prelude Therapeutics Inc | CEO, Director | Common Stock | 121K | $455K | $3.77 | May 24, 2023 | Indirect |
| Prelude Therapeutics Inc | CEO, Director | Employee Stock Option (right to buy) | 425K | Mar 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | Mar 1, 2024 | 1 | $0 | 4 | Mar 4, 2024 | CEO, Director |
| PRLD | Prelude Therapeutics Inc | May 24, 2023 | 2 | $9.79K | 4 | May 26, 2023 | CEO, Director |
| PRLD | Prelude Therapeutics Inc | May 23, 2023 | 1 | $66.7K | 4 | May 25, 2023 | CEO, Director |
| PRLD | Prelude Therapeutics Inc | Feb 7, 2023 | 1 | $0 | 4 | Feb 9, 2023 | CEO, Director |
| PRLD | Prelude Therapeutics Inc | Dec 20, 2022 | 1 | $98.4K | 4 | Dec 21, 2022 | CEO, Director |
| PRLD | Prelude Therapeutics Inc | Feb 15, 2022 | 1 | $0 | 4 | Feb 17, 2022 | CEO, Director |
| PRLD | Prelude Therapeutics Inc | Dec 13, 2021 | 1 | $97K | 4 | Dec 14, 2021 | President, CEO, Director |
| PRLD | Prelude Therapeutics Inc | Jul 20, 2021 | 1 | $0 | 4 | Jul 22, 2021 | President, CEO, Director |